Sophisticated solid dose formulations for fixed dose combinations – Jean-François Hilaire, Recipharm, explains how CDMOs can help optimise time-to-market
Demanding situation: There is an increasing demand for capabilities that support the formulation and development of fixed-dose combination drugs, says Recipharm